Other languages Arctic Bioscience

Equities

ABS

NO0010859580

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-05-10 EDT			5-day change	1st Jan Change
10.1 ^NOK	-2.88%		-3.81%	-3.81%

03-01	Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-01	Transcript : Arctic Bioscience AS, Q4 2023 Earnings Call, Mar 01, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023	03-01
Arctic Bioscience Announces Treatment start for 519 patients in the HeROPA-Study	02-28
Arctic Bioscience Completes Patient Enlistment for Psoriasis Drug Candidate’s Mid-stage Study	01-17
Arctic Bioscience Announces Recruitment Completed in the Phase IIb HeROPA Clinical Trial	01-17
Arctic Bioscience AS Provides Revenue Guidance for the Year 2023	11-02
Arctic Bioscience AS Provides Earnings Guidance for the Year 2023	23-08-29
Arctic Bioscience AS Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28
Arctic Bioscience as Announces Operational Update - Heropa Clinical Trial Approved in All 5 Countries and Ongoing	23-05-08
Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29
Arctic Bioscience Secures Approval for Psoriasis Treatment Trial in Norway, Finland, Germany, Poland	23-03-07
Arctic Bioscience - The HeROPA phase IIb clinical trial approved in Norway, Finland, Germany and Poland	23-03-07
Arctic Bioscience Buys Norwegian Microalgae Producer Arctic Algae	23-02-13
Arctic Bioscience AS (OB:ABS) acquired Arctic Algae As from Ronja Capital II AS for enterprise value NOK 16.3 million.	23-02-12
Arctic Bioscience Recruits First Patient For UK Psoriasis Investigational Medication Trial	23-02-01
Arctic Bioscience Announces First Patient Included in HRO350 Phase IIb Clinical Trial in the UK	23-01-31
UK Regulators Approve Arctic Bioscience's Clinical Trial Application For Psoriasis Medication	23-01-12
Arctic Bioscience Announces Clinical Trial Application for HRO350 Phase IIb Approves in UK	23-01-12
Arctic Bioscience as Maintains Earnings Guidance for the Year 2022	22-10-31
Norway's Arctic Bioscience Submits Application To Launch Mid-stage Trial Of Psoriasis Drug	22-10-10
Arctic Bioscience Submits Clinical Trial Application for Hro350 Phase IIb	22-10-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Arctic Bioscience

Equities

ABS

NO0010859580

Other languages

Filters